Home | BioSenic

Our Executive Team

Products

BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for inflammatory diseases and bone disorders, as well as medical devices for these same areas.

Investors

All regulatory information and reports.

Clinical studies

Learn more about clinical development and our ongoing studies.

BioSenic publie ses résultats pour le premier semestre 2025

Our technology

BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for inflammatory diseases and bone disorders.

Stock information

BioSenic ( BIOS )

0.0025€

28.10.2025

New SOLUTIONS

New SOLUTIONS

New SOLUTIONS

Our Executive Team

Products

Investors

Clinical studies

Our technology

Stock information

Sign upfor our press releases